GERON CORP's ticker is GERN and the CUSIP is 374163103. A total of 105 filers reported holding GERON CORP in Q3 2013. The put-call ratio across all filers is 3.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,864 | +762.1% | 12,200 | +1120.0% | 0.00% | -100.0% |
| Q2 2018 | $3,000 | -25.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $4,000 | +100.0% | 1,000 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $2,000 | -33.3% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $3,000 | +50.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $2,000 | -33.3% | 1,000 | 0.0% | 0.00% | -33.3% |
| Q2 2016 | $3,000 | 0.0% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q1 2016 | $3,000 | -95.5% | 1,000 | -95.0% | 0.01% | -97.9% |
| Q3 2013 | $67,000 | +123.3% | 20,000 | 0.0% | 0.29% | +728.6% |
| Q2 2013 | $30,000 | – | 20,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 5,732,770 | $7,854,000 | 1.22% |
| RA Capital Management | 30,126,299 | $41,273,000 | 0.57% |
| NEA Management Company, LLC | 13,461,538 | $18,442,000 | 0.22% |
| Virtus ETF Advisers LLC | 146,618 | $201,000 | 0.09% |
| Forefront Analytics, LLC | 82,336 | $113,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 226,098 | $310,000 | 0.03% |
| Summit X, LLC | 84,077 | $114,000 | 0.03% |
| Poehling Capital Management, INC. | 53,000 | $73,000 | 0.02% |
| Arnhold LLC | 154,700 | $212,000 | 0.02% |
| Vishria Bird Financial Group, LLC | 20,615 | $28,000 | 0.02% |